|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Merck & Co. Inc.
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-04-08 Purchase |
2019-04-09 6:27 pm |
NGM BIOPHARMACEUTICALS INC | NGM | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
4,121,683 | $16 | $65,946,928 | 12,955,016 (Indirect) |
View |
| 2019-03-25 Sale |
2019-03-27 5:45 pm |
Merck & Co. Inc. | MRK | Davis Robert M CFO |
192,572 | $82.38 | $15,863,118 | 330,232 (Direct) |
View |
| 2019-03-20 Sale |
2019-03-20 6:49 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
192,736 | $82.05 | $15,813,372 | 990,451 (Indirect Direct) |
View |
| 2019-03-13 Sale |
2019-03-14 6:38 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
18,725 | $82 | $1,535,454 | 816,440 (Indirect Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 6:13 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
20,105 | $82 | $1,648,684 | 810,859 (Indirect Direct) |
View |
| 2019-02-21 Sale |
2019-02-22 5:16 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
95,953 | $80.01 | $7,677,541 | 745,911 (Indirect Direct) |
View |
| 2019-02-15 Sale |
2019-02-19 5:35 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
135,613 | $80.03 | $10,853,106 | 784,863 (Indirect Direct) |
View |
| 2019-02-12 Sale |
2019-02-14 6:02 pm |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
73,727 | $78.62 | $5,796,306 | 125,194 (Direct) |
View |
| 2019-02-13 Sale |
2019-02-14 6:02 pm |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
5,000 | $78.71 | $393,548 | 5,100 (Direct) |
View |
| 2019-02-14 Sale |
2019-02-14 6:02 pm |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
64,662 | $78.96 | $5,105,951 | 80,837 (Direct) |
View |
| 2019-02-08 Sale |
2019-02-11 5:33 pm |
Merck & Co. Inc. | MRK | BRUN LESLIE A Director |
3,052 | $77.22 | $235,681 | 5,000 (Direct) |
View |
| 2019-02-05 Sale |
2019-02-06 5:30 pm |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
231,566 | $78.08 | $18,079,654 | 923,516 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-04 5:44 pm |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
10,000 | $75.96 | $759,590 | 15,100 (Direct) |
View |
| 2018-11-07 Sale |
2018-11-08 4:31 pm |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
36,218 | $75.14 | $2,721,348 | 82,481 (Direct) |
View |
| 2018-11-08 Sale |
2018-11-08 4:31 pm |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
225,443 | $75.26 | $16,967,967 | 366,998 (Direct) |
View |
| 2018-11-01 Sale |
2018-11-02 4:44 pm |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
277,879 | $73.81 | $20,510,944 | 277,879 (Indirect Direct) |
View |
| 2018-10-30 Sale |
2018-11-01 5:07 pm |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
25,467 | $72 | $1,833,739 | 82,135 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-04-08 Conversion |
2019-04-09 6:27 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
8,833,333 | $0 | 12,955,016 (Indirect) |
View |
| 2019-04-08 Conversion |
2019-04-09 6:27 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner |
17,666,666 | $0 | 12,955,016 (Indirect) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
346 | $83.17 | 87,430 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
346 | $83.17 | 86,377 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | THULIN INGE G Director |
346 | $83.17 | 5,266 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Noseworthy John H Director |
346 | $83.17 | 9,225 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | LAZARUS ROCHELLE B Director |
346 | $83.17 | 81,616 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
406 | $83.17 | 63,095 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:58 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Coe Mary Ellen Director |
57 | $83.17 | 135 (Direct) |
View |
| 2019-03-25 Exercise |
2019-03-27 5:45 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Davis Robert M CFO |
192,572 | $58.22 | 330,232 (Direct) |
View |
| 2019-03-25 Exercise |
2019-03-27 5:45 pm |
2015-05-09 2024-05-08 |
Merck & Co. Inc. | MRK | Davis Robert M CFO |
192,572 | $58.22 | 330,232 (Direct) |
View |
| 2019-03-18 Option Award |
2019-03-20 6:49 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Coe Mary Ellen Director |
79 | $81.35 | 79 (Direct) |
View |
| 2019-03-20 Exercise |
2019-03-20 6:49 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
192,736 | $39.29 | 990,451 (Direct) |
View |
| 2019-03-20 Exercise |
2019-03-20 6:49 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
192,736 | $39.29 | 990,451 (Direct) |
View |
| 2019-03-13 Exercise |
2019-03-14 6:38 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
18,725 | $39.29 | 816,440 (Direct) |
View |
| 2019-03-13 Exercise |
2019-03-14 6:38 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
18,725 | $39.29 | 816,440 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-06 6:13 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
13,144 | $39.29 | 810,859 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-06 6:13 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
6,961 | $39.29 | 810,859 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-06 6:13 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
13,144 | $39.29 | 810,859 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-06 6:13 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
6,961 | $39.29 | 810,859 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
32,937 | $80.38 | 175,336 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Nally Michael EVP, Chief Marketing Officer |
1,527 | $80.38 | 1,527 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
2,330 | $80.38 | 18,505 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
8,747 | $80.38 | 55,288 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
105,765 | $80.38 | 797,715 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
13,507 | $80.38 | 70,585 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:54 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Davis Robert M CFO |
30,610 | $80.38 | 137,660 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:54 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Clyburn Frank EVP, Chief Commercial Officer |
4,017 | $80.38 | 66,189 (Direct) |
View |
| 2019-02-25 Option Award |
2019-02-27 6:54 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
10,380 | $80.38 | 61,847 (Direct) |
View |
| 2019-02-21 Exercise |
2019-02-22 5:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
41,992 | $39.29 | 745,911 (Direct) |
View |
| 2019-02-21 Exercise |
2019-02-22 5:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
53,961 | $39.29 | 745,911 (Direct) |
View |
| 2019-02-21 Exercise |
2019-02-22 5:16 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
41,992 | $39.29 | 745,911 (Direct) |
View |
| 2019-02-21 Exercise |
2019-02-22 5:16 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
53,961 | $39.29 | 745,911 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-19 5:35 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
92,913 | $39.29 | 784,863 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-19 5:35 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
42,700 | $39.29 | 784,863 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-19 5:35 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
92,913 | $39.29 | 784,863 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-19 5:35 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
42,700 | $39.29 | 784,863 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
43,876 | $39.29 | 125,194 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
29,851 | $36.56 | 125,194 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
43,876 | $39.29 | 125,194 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:02 pm |
2012-05-04 2021-05-03 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat VP |
29,851 | $36.56 | 125,194 (Direct) |
View |
| 2019-02-13 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
5,000 | $24.3 | 5,100 (Direct) |
View |
| 2019-02-13 Exercise |
2019-02-14 6:02 pm |
2010-05-01 2019-04-30 |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
5,000 | $24.3 | 5,100 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
37,152 | $59.86 | 80,837 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
27,510 | $58.22 | 80,837 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
2016-05-01 2025-04-30 |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
37,152 | $59.86 | 80,837 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-14 6:02 pm |
2015-05-09 2024-05-08 |
Merck & Co. Inc. | MRK | Karachun Rita A VP |
27,510 | $58.22 | 80,837 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 5:33 pm |
N/A N/A |
Merck & Co. Inc. | MRK | BRUN LESLIE A Director |
5,000 | $24.3 | 5,000 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 5:33 pm |
2010-05-01 2019-04-30 |
Merck & Co. Inc. | MRK | BRUN LESLIE A Director |
5,000 | $24.3 | 5,000 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-06 5:30 pm |
N/A N/A |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
231,566 | $39.29 | 923,516 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-06 5:30 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | FRAZIER KENNETH C CEO, Chairman |
231,566 | $39.29 | 923,516 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $35.19 | 15,100 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $24.3 | 15,100 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
2010-05-01 2019-04-30 |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $24.3 | 15,100 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-04 5:44 pm |
2011-08-04 2020-08-03 |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
5,000 | $35.19 | 15,100 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
376 | $76.41 | 86,461 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WEEKS WENDELL P Director |
376 | $76.41 | 85,416 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | THULIN INGE G Director |
376 | $76.41 | 4,887 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Noseworthy John H Director |
376 | $76.41 | 8,818 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:27 pm |
N/A N/A |
Merck & Co. Inc. | MRK | LAZARUS ROCHELLE B Director |
376 | $76.41 | 80,689 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 5:25 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
442 | $76.41 | 62,242 (Direct) |
View |
| 2018-11-07 Exercise |
2018-11-08 4:31 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
36,218 | $54.68 | 82,481 (Direct) |
View |
| 2018-11-07 Exercise |
2018-11-08 4:31 pm |
2017-05-10 2026-05-09 |
Merck & Co. Inc. | MRK | Gerberding Julie L. VP |
36,218 | $54.68 | 82,481 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-08 4:31 pm |
N/A N/A |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
225,443 | $44.98 | 366,998 (Direct) |
View |
| 2018-11-08 Exercise |
2018-11-08 4:31 pm |
2014-05-06 2023-05-05 |
Merck & Co. Inc. | MRK | PERLMUTTER ROGER M VP |
225,443 | $44.98 | 366,998 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-02 4:44 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
277,879 | $39.29 | 277,879 (Direct) |
View |
| 2018-11-01 Exercise |
2018-11-02 4:44 pm |
2013-05-02 2022-05-01 |
Merck & Co. Inc. | MRK | Schechter Adam H VP |
277,879 | $39.29 | 277,879 (Direct) |
View |
| 2018-10-30 Exercise |
2018-11-01 5:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
25,467 | $34.19 | 82,135 (Direct) |
View |
| 2018-10-30 Exercise |
2018-11-01 5:07 pm |
2012-11-02 2021-11-01 |
Merck & Co. Inc. | MRK | DeLuca Richard R. VP |
25,467 | $34.19 | 82,135 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 24 Apr 2019 13:13:10 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |